Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Neelima Ayyalasomayajula & Challa Suresh. (2018) Mechanistic comparison of current pharmacological treatments and novel phytochemicals to target amyloid peptides in Alzheimer’s and neurodegenerative diseases. Nutritional Neuroscience 21:10, pages 682-694.
Read now
Read now
Articles from other publishers (26)
Sehnaz Ferdosh, Senjuti Banerjee, Jayshree Singh & Chandana Barat. (2022) Amyloid protein‐induced sequestration of the eukaryotic ribosome: effect of stoichiometry and polyphenolic inhibitors. FEBS Letters 596:9, pages 1190-1202.
Crossref
Crossref
Masahiro Kawahara, Midori Kato-Negishi & Ken-ichiro Tanaka. (2020) Amyloids: Regulators of Metal Homeostasis in the Synapse. Molecules 25:6, pages 1441.
Crossref
Crossref
Allison B. Reiss, Hirra A. Arain, Mark M. Stecker, Nicolle M. Siegart & Lora J. Kasselman. (2018) Amyloid toxicity in Alzheimer’s disease. Reviews in the Neurosciences 29:6, pages 613-627.
Crossref
Crossref
B.V. Foroutanpay, J. Kumar, S.G. Kang, N. Danaei, D. Westaway, V.L. Sim & S. Kar. (2018) The Effects of N-terminal Mutations on β-amyloid Peptide Aggregation and Toxicity. Neuroscience 379, pages 177-188.
Crossref
Crossref
Montserrat Serra-Batiste, Martí Ninot-Pedrosa, Eduard Puig, Sonia Ciudad, Margarida Gairí & Natàlia Carulla. 2018. Amyloid Proteins. Amyloid Proteins
13
22
.
Katie L. Stewart & Sheena E. Radford. (2017) Amyloid plaques beyond Aβ: a survey of the diverse modulators of amyloid aggregation. Biophysical Reviews 9:4, pages 405-419.
Crossref
Crossref
Carlos Perez, Jokubas Ziburkus & Ghanim Ullah. (2016) Analyzing and Modeling the Dysfunction of Inhibitory Neurons in Alzheimer’s Disease. PLOS ONE 11:12, pages e0168800.
Crossref
Crossref
Attila Somogyi, Zoltán Katonai, Alán Alpár & Ervin Wolf. (2016) A Novel Form of Compensation in the Tg2576 Amyloid Mouse Model of Alzheimer’s Disease. Frontiers in Cellular Neuroscience 10.
Crossref
Crossref
Heledd H. Jarosz-Griffiths, Elizabeth Noble, Jo V. Rushworth & Nigel M. Hooper. (2016) Amyloid-β Receptors: The Good, the Bad, and the Prion Protein. Journal of Biological Chemistry 291:7, pages 3174-3183.
Crossref
Crossref
Pierfausto Seneci. 2015. Molecular Targets in Protein Misfolding and Neurodegenerative Disease. Molecular Targets in Protein Misfolding and Neurodegenerative Disease
229
276
.
Rustam Azimov & Bruce L. Kagan. 2015. Electrophysiology of Unconventional Channels and Pores. Electrophysiology of Unconventional Channels and Pores
343
360
.
Tae-In Kam, Youngdae Gwon & Yong-Keun Jung. (2014) Amyloid beta receptors responsible for neurotoxicity and cellular defects in Alzheimer’s disease. Cellular and Molecular Life Sciences 71:24, pages 4803-4813.
Crossref
Crossref
I. W. Hamley. (2012) The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization. Chemical Reviews 112:10, pages 5147-5192.
Crossref
Crossref
Nils Norlin, Magnus Hellberg, Andrei Filippov, Alioscka A. Sousa, Gerhard Gröbner, Richard D. Leapman, Nils Almqvist & Oleg N. Antzutkin. (2012) Aggregation and fibril morphology of the Arctic mutation of Alzheimer’s Aβ peptide by CD, TEM, STEM and in situ AFM. Journal of Structural Biology 180:1, pages 174-189.
Crossref
Crossref
Michele F.M. Sciacca, Samuel A. Kotler, Jeffrey R. Brender, Jennifer Chen, Dong-kuk Lee & Ayyalusamy Ramamoorthy. (2012) Two-Step Mechanism of Membrane Disruption by Aβ through Membrane Fragmentation and Pore Formation. Biophysical Journal 103:4, pages 702-710.
Crossref
Crossref
Bruce L. Kagan. 2012. Molecular Biology of Neurodegenerative Diseases. Molecular Biology of Neurodegenerative Diseases
295
325
.
Angelo Demuro, Martin Smith & Ian Parker. (2011) Single-channel Ca2+ imaging implicates Aβ1–42 amyloid pores in Alzheimer’s disease pathology. Journal of Cell Biology 195:3, pages 515-524.
Crossref
Crossref
Grace E. Stutzmann & Mark P. Mattson. (2011)
Endoplasmic Reticulum Ca
2+
Handling in Excitable Cells in Health and Disease
. Pharmacological Reviews 63:3, pages 700-727.
Crossref
Crossref
Agenor Limon, Jorge Mauricio Reyes-Ruiz & Ricardo Miledi. (2011) GABAergic drugs and Alzheimer’s disease. Future Medicinal Chemistry 3:2, pages 149-153.
Crossref
Crossref
Fiorella Malchiodi-Albedi, Silvia Paradisi, Andrea Matteucci, Claudio Frank & Marco Diociaiuti. (2011) Amyloid Oligomer Neurotoxicity, Calcium Dysregulation, and Lipid Rafts. International Journal of Alzheimer's Disease 2011, pages 1-17.
Crossref
Crossref
Masahiro Kawahara, Isao Ohtsuka, Shoko Yokoyama, Midori Kato-Negishi & Yutaka Sadakane. (2011)
Membrane Incorporation, Channel Formation, and Disruption of Calcium Homeostasis by Alzheimer's
β
-Amyloid Protein
. International Journal of Alzheimer's Disease 2011, pages 1-17.
Crossref
Crossref
Sara M. Butterfield & Hilal A. Lashuel. (2010) Amyloidogenic Protein–Membrane Interactions: Mechanistic Insight from Model Systems. Angewandte Chemie International Edition 49:33, pages 5628-5654.
Crossref
Crossref
Sara M. Butterfield & Hilal A. Lashuel. (2010) Wechselwirkungen zwischen amyloidogenen Proteinen und Membranen: Modellsysteme liefern mechanistische Einblicke. Angewandte Chemie 122:33, pages 5760-5788.
Crossref
Crossref
Angelo Demuro, Ian Parker & Grace E. Stutzmann. (2010) Calcium Signaling and Amyloid Toxicity in Alzheimer Disease. Journal of Biological Chemistry 285:17, pages 12463-12468.
Crossref
Crossref
Siu-Kei ChowDiana YuChristopher L MacDonaldMarius BuibasGabriel A Silva. (2010) Amyloid β-Peptide Directly Induces Spontaneous Calcium Transients, Delayed Intercellular Calcium Waves and Gliosis in Rat Cortical Astrocytes. ASN Neuro 2:1, pages AN20090035.
Crossref
Crossref
Susana Ferrao Santos, Nathalie Pierrot & Jean-Noel Octave. (2010) Network Excitability Dysfunction in Alzheimer's Disease: Insights from In Vitro and In Vivo Models. Reviews in the Neurosciences 21:3.
Crossref
Crossref